The FDA on Friday approved the first at-home flu vaccine in the U.S., a nasal spray.

The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration.

Starting next flu season, people who want to order the vaccine to give it to themselves or their children at home will be able to do so.

FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages of 2 and 49. This FDA approval makes it the only flu vaccine in the United States that can be administered at home and that does not need to be administered by a health care professional.

  • @deafboyEnglish
    2•3 days ago

    I was under the impression that attenuated live vaccines are only used in poor countries due to lower cost.